UPCOMING SESSIONS in ET
Tue, Jul 28, 2026
5:00 – 6:00 AM Bangkok
The Importance of Communicating with Your Health Care Team Edelyn (Ed) Yhip Click Here To Register
UPCOMING SESSIONS in ET
Tue, Jul 28, 2026 · 5:00 – 6:00 AM Bangkok
The Importance of Communicating with Your Health Care Team
Edelyn (Ed) Yhip
Click Here To Register
View all sessions
Apr 13, 2026
Fourth annual online conference about the challenges and opportunities in understanding and treating rare cardiac conditions. Subconference Session Moderator: Dr.…
Apr 11, 2026
Transthyretin amyloid cardiomyopathy, also known as ATTR-CM, is a life-threatening disease of the heart muscle. Symptoms are sometimes similar to those experienced…
Apr 09, 2026
We're starting to show our audience a series of reports on rare heart diseases, featuring cardiologist Dr. André. Across all platforms of Jornal Acontece and TV…
Apr 08, 2026
Acoramidis reduces both all-cause mortality and hospitalizations, but it also showed the need for early diagnosis and prompt therapy. #ATTR_CM #ATTR #Amyloidosis #…
Apr 07, 2026
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) negatively impacts cardiac function, overall health, and quality of life (QOL). The gradual buildup of…
Apr 06, 2026
I’m focusing on a new game – my heart game. That’s because I’m living with ATTR-CM, a rare, progressive heart condition. It took years before I was diagnosed…
Apr 06, 2026
Most people have never come across the word amyloidosis and that’s part of the problem.It’s a cause of heart failure that still gets missed, even when the clues…
Apr 05, 2026
Hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN), also known as familial amyloid polyneuropathy, is a rare inherited condition that damages…
Apr 04, 2026
Most people have never come across the word amyloidosis and that’s part of the problem.It’s a cause of heart failure that still gets missed, even when the clues…
Mar 31, 2026
This #AmyloidosisAwarenessMonth, we’re honored to share Anne Marie and Gesna’s perspectives on the progress made in the amyloidosis community in the years since…